Top Stories

Familial Hypercholesterolemia (with Christie Ballantyne, MD)

Familial Hypercholesterolemia (FH) is among the most common genetic lipid disorders; left untreated, FH patients have a 20-fold increased risk for CHD.   Primary Issues Website - July 24, 2011

NEXLETOL™ (Bempedoic Acid), a New LDL-C Lowering Therapy, Now Available in U.S. Pharmacies

Esperion has announced that NEXLETOL™ (bempedoic acid) is now available in pharmacies in the United States. NEXLETOL is an oral, once-daily, tablet indicated as an adjunct to diet and maximally tolerated statin for the treatment of adults with heterozygous familial hypercholesterolemia (HeFH... more

Doctors Look Anew at Puzzle of Cholesterol

For heart health, you're supposed to know your numbers: total cholesterol, the bad LDL kind and the good HDL kind.   Associated Press - November 7, 2011

LIPTRUZET is Approved by U.S. FDA

On Friday, May 3, the U.S. FDA approved LIPTRUZET (ezetimibe and atorvastatin) tablets for the treatment of elevated low-density lipoprotein (LDL) cholesterol in patients with primary or mixed hyperlipidemia as adjunctive therapy to diet when diet alone is not enough. For more information, please... more

NEXLIZET™ (Bempedoic Acid and Ezetimibe) Now Available in U.S. Pharmacies

Esperion has announced that NEXLIZET™ (bempedoic acid and ezetimibe) Is now available in pharmacies in the United States. NEXLIZET™ is an oral, once-daily, fixed-dose combination tablet indicated as an adjunct to diet and maximally tolerated statin for the treatment of adults with heterozygous... more